Empiric Management of Early Lyme Disease (Erythema Migrans)

Adult First‑Line Antibiotic Regimens

The Infectious Diseases Society of America (IDSA) recommends three equally effective oral options for adults with clinically diagnosed erythema migrans.

Evidence of efficacy: Prospective randomized trials show complete response rates > 83 % at 30 months for all three agents, with no statistically significant differences. High‑quality evidence. 1

Preference for Doxycycline

Pediatric Dosing (IDSA)

Special Populations – Pregnancy & Lactation

Clinical Diagnosis Without Laboratory Testing

Distinguishing True Erythema Migrans from Tick‑Bite Hypersensitivity

Administration Considerations for Doxycycline

Ineffective Antibiotics & Pitfalls

Recommended Treatment Duration

All recommendations are derived from IDSA guidelines and supported by the cited peer‑reviewed literature.

Antibiotic Regimens for Early Lyme Disease

Introduction to Treatment Regimens

• The Infectious Diseases Society of America recommends doxycycline 100 mg twice daily for 10-21 days, amoxicillin 500 mg three times daily for 14-21 days, and cefuroxime axetil 500 mg twice daily for 14-21 days as first-line oral antibiotic regimens for treating early Lyme disease in adults 6, 7

Adult Dosing Regimens

• The American College of Physicians suggests that doxycycline dosage is 100 mg orally twice daily, with a duration of 14 days (range 10-21 days) 6, 7, 8
• The Infectious Diseases Society of America recommends amoxicillin dosage of 500 mg orally three times daily, with a duration of 14-21 days 6, 7, 8
• The American Academy of Family Physicians suggests that cefuroxime axetil dosage is 500 mg orally twice daily, with a duration of 14-21 days 6, 7, 8

Pediatric Dosing Regimens

• The American Academy of Pediatrics recommends doxycycline dosage of 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) for 14 days for children ≥8 years old 6, 8, 9
• The American Academy of Pediatrics suggests amoxicillin dosage of 50 mg/kg per day in 3 divided doses (maximum 500 mg per dose) for 14 days for children <8 years old 6, 8, 9

Clinical Trial Evidence Supporting These Regimens

• Multiple prospective randomized controlled trials demonstrated comparable efficacy across all three regimens, with no difference in complete response rates (83.9% vs 90.3% at 30 months, P > 0.2) 6, 7

Important Administration Considerations

• Doxycycline should be taken with 8 ounces of fluid to reduce esophageal irritation and with food to minimize gastrointestinal intolerance, and patients must avoid sun exposure due to photosensitivity risk 7, 10
• Doxycycline is relatively contraindicated in pregnant or lactating women and children under 8 years of age 6, 8

Common Pitfalls to Avoid

• First-generation cephalosporins (e.g., cephalexin) are inactive against B. burgdorferi and should never be used 8, 9
• Macrolide antibiotics (azithromycin, clarithromycin, erythromycin) are less effective than the three first-line regimens and should only be reserved for patients intolerant of all first-line options 6, 7, 8
• Extending treatment beyond 21 days is not supported by evidence and does not improve outcomes 7

Cefuroxima Axetil para Enfermedad de Lyme Cutánea

Cálculo de la Dosis Pediátrica

• La dosis pediátrica estándar de cefuroxima axetil es 30 mg/kg/día dividida en 2 dosis, con un máximo de 500 mg por dosis, según el Clinical Infectious Diseases 11
• Para una niña de 28 kg: 30 mg/kg/día × 28 kg = 840 mg/día total, lo que se divide en 420 mg cada 12 horas (dos veces al día) 11
• Esta dosis está por debajo del máximo de 500 mg por dosis, por lo que no requiere ajuste 11

Duración del Tratamiento

• La duración recomendada es de 14 días para cefuroxima axetil en enfermedad de Lyme cutánea temprana, según el Clinical Infectious Diseases 11

Justificación de Cefuroxima en Esta Paciente

• Cefuroxima axetil es una opción de primera línea apropiada para niños menores de 8 años con enfermedad de Lyme cutánea, según el Clinical Infectious Diseases 11
• La amoxicilina (50 mg/kg/día en 3 dosis) es la opción preferida, pero cefuroxima axetil es una alternativa equivalente cuando la amoxicilina no es tolerada o apropiada 11
• La doxiciclina está contraindicada en niños menores de 8 años, por lo que no es una opción para esta paciente de 6 años 11

Errores Comunes a Evitar

• Nunca usar cefalosporinas de primera generación (como cefalexina), ya que son completamente inactivas contra Borrelia burgdorferi y clínicamente ineficaces, según el Clinical Infectious Diseases 11
• No confundir la dosis de cefuroxima intravenosa (50-75 mg/kg/día) con la dosis oral de cefuroxima axetil (30 mg/kg/día) 11
• Los macrólidos (azitromicina, claritromicina) son menos eficaces que los agentes de primera línea y solo deben reservarse para pacientes intolerantes a todas las opciones de primera línea 11

Monitoreo y Seguimiento

• Los pacientes tratados con antibióticos alternativos como cefuroxima deben ser observados cuidadosamente para asegurar la resolución de las manifestaciones clínicas, según el Clinical Infectious Diseases 11